John J. Schwartz
Präsident bei Quantum Strategies Management Co.
Profil
John J.
Schwartz is currently the President of Quantum Strategies Management Co. He was previously the President & CEO of Systemix, Inc., Chairman of StemCells, Inc., and Vice President & General Counsel of Stanford University.
He holds a doctorate degree from the University of Rochester and a graduate degree from Harvard Law School.
Aktive Positionen von John J. Schwartz
| Unternehmen | Position | Beginn |
|---|---|---|
Quantum Strategies Management Co.
 Quantum Strategies Management Co. Investment ManagersFinance Quantum Strategies Management Co. provides investment advice. The private company is based in Palo Alto, CA. | Präsident | 27.07.2009 |
Ehemalige bekannte Positionen von John J. Schwartz
| Unternehmen | Position | Ende |
|---|---|---|
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Präsident | - |
| Stanford University | General Counsel | - |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Vorsitzender | - |
Ausbildung von John J. Schwartz
| Rochester Christian University | Doctorate Degree |
| Harvard Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Quantum Strategies Management Co.
Quantum Strategies Management Co. Investment ManagersFinance Quantum Strategies Management Co. provides investment advice. The private company is based in Palo Alto, CA. | Finance |